NEOLA — Neola Medical AB Income Statement
0.000.00%
Last trade - 00:00
- SEK143.11m
- SEK121.53m
- 23
- 23
- 64
- 27
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.016 | 0.031 | 0.625 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 1.85 | 1.54 | 9.05 | 8.02 | 8.02 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.62 | 6.75 | 7.28 | 10.4 | 9.62 |
Operating Profit | -2.61 | -6.72 | -6.65 | -10.4 | -9.62 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.61 | -6.72 | -6.65 | -10.4 | -9.01 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.61 | -6.72 | -6.65 | -10.4 | -9.01 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.61 | -6.72 | -6.65 | -10.4 | -9.01 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.61 | -6.72 | -6.65 | -10.4 | -9.01 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.195 | -0.734 | -0.366 | -0.397 | -0.162 |
Dividends per Share |